Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Parsons (PSN) Q2 EPS Beats by 5%
Parsons (PSN) Q2 EPS Beats by 5%

Parsons (NYSE:PSN), a global provider of technology-driven solutions for critical infrastructure, defense, and cybersecurity, released its Q2 FY2025 earnings on August 6, 2025. The company delivered

Why Scholar Rock Stock Wilted on Wednesday
Why Scholar Rock Stock Wilted on Wednesday

It didn't take a high-powered academic to figure out why Scholar Rock's (NASDAQ: SRRK) share price swooned by more than 5% on Wednesday. That morning, the biotech published a quarterly earnings

Avista (AVA) Q2 EPS Drops 41%
Avista (AVA) Q2 EPS Drops 41%

Avista (NYSE:AVA), a regional regulated electric and natural gas utility serving the Pacific Northwest and Alaska, reported earnings on August 5, 2025, for the second quarter of fiscal 2025. The

COPT Defense Properties (CDP) Q2 2025 Earnings Transcript
COPT Defense Properties (CDP) Q2 2025 Earnings Transcript

Image source: The Motley Fool.

Tuesday, July 29, 2025, at 12 p.m. ET

Need a quote from a Motley Fool analyst? Email [email protected]

Continue reading

Source Fool.com

OptimumBank (OPHC) Q2 EPS Jumps 93%
OptimumBank (OPHC) Q2 EPS Jumps 93%

OptimumBank (NYSEMKT:OPHC), a community bank focused on the South Florida market, reported its Q2 2025 earnings on August 6, 2025. The most notable news in this release was a significant

Amentum (AMTM) Q3 Revenue Jumps 66%
Amentum (AMTM) Q3 Revenue Jumps 66%

Amentum (NYSE:AMTM), a leading provider of engineering, technical, and mission support services to government and commercial customers, reported results for Q3 FY2025 on August 5, 2025. The earnings

Scholar Rock (SRRK) Q2 Loss Widens 63%
Scholar Rock (SRRK) Q2 Loss Widens 63%

Scholar Rock (NASDAQ:SRRK), a late-stage biopharmaceutical company specializing in therapies for serious neuromuscular and rare diseases, released its second quarter 2025 earnings on August 6, 2025

Bentley (BSY) Q2 Revenue Up 10%
Bentley (BSY) Q2 Revenue Up 10%

Bentley Systems (NASDAQ:BSY), a global provider of infrastructure engineering software, reported its second quarter 2025 financial results on August 6, 2025. The most notable outcome was a beat on

Howard Hughes (HHH) Q2 EPS Falls 123%
Howard Hughes (HHH) Q2 EPS Falls 123%

Howard Hughes (NYSE:HHH), a leading developer of master planned communities and mixed-use real estate, reported earnings for Q2 FY2025 on August 6, 2025. The headline news from the release was a

Lexicon (LXRX) Q2 Revenue Soars 1,706%
Lexicon (LXRX) Q2 Revenue Soars 1,706%

Lexicon Pharmaceuticals (NASDAQ:LXRX), a biopharma company focused on developing treatments for diabetes, cardiovascular, and neurological diseases, released its second quarter 2025 financial

AtriCure (ATRC) Q2 2025 Earnings Call Transcript
AtriCure (ATRC) Q2 2025 Earnings Call Transcript

Image source: The Motley Fool.

Tuesday, July 29, 2025, at 4:30 p.m. ET

Need a quote from a Motley Fool analyst? Email [email protected]

Continue reading

Source Fool.com

RYAM Sales Drop 19%
RYAM Sales Drop 19%

Rayonier Advanced Materials (NYSE:RYAM), a leading manufacturer of high-purity cellulose and related plant-based products, reported Q2 FY2025 earnings on August 5, 2025. The earnings release

Adient (ADNT) Q3 Revenue Up 0.7%
Adient (ADNT) Q3 Revenue Up 0.7%

Adient (NYSE:ADNT), a leading global manufacturer specializing in automotive seating systems for major vehicle producers, released its fiscal third-quarter earnings on August 6, 2025. The most

American Coastal (ACIC) Q2 EPS Jumps 36%
American Coastal (ACIC) Q2 EPS Jumps 36%

American Coastal Insurance (NASDAQ:ACIC), a specialist in Florida commercial residential insurance, reported its second quarter 2025 financial results on August 6, 2025. The company posted diluted

APEI Earnings Rise 6%
APEI Earnings Rise 6%

American Public Education (NASDAQ:APEI), an online and campus-based provider specializing in military, nursing, and public service education, released its second quarter results on August 6, 2025

Centuri (CTRI) Q2 Revenue Jumps 8%
Centuri (CTRI) Q2 Revenue Jumps 8%

Centuri (NYSE:CTRI), a major North American utility infrastructure services provider, reported its fiscal second quarter 2025 results on August 6, 2025. The headline news was strong revenue, which

Ameris (ABCB) Q2 2025 Earnings Call Transcript
Ameris (ABCB) Q2 2025 Earnings Call Transcript

Image source: The Motley Fool.

Tuesday, July 29, 2025, at 9 a.m. ET

Need a quote from one of our analysts? Email [email protected]

Continue reading

Source Fool.com

EyePoint (EYPT) Q2 Revenue Drops 44%
EyePoint (EYPT) Q2 Revenue Drops 44%

EyePoint Pharmaceuticals (NASDAQ:EYPT), a biopharmaceutical company specializing in sustained-release treatments for retinal diseases, reported its second quarter 2025 results on August 6, 2025. The

Dave (DAVE) Q2 EPS Jumps 211%
Dave (DAVE) Q2 EPS Jumps 211%

Dave (NASDAQ:DAVE), a digital finance platform focused on providing banking and credit solutions to financially vulnerable Americans, released its second quarter fiscal 2025 earnings on August 6

NRP Net Income Drops 26%
NRP Net Income Drops 26%

Natural Resource Partners (NYSE:NRP), a diversified owner of mineral rights and interests primarily in coal and soda ash, released its Q2 2025 results on Aug. 6, 2025. In this earnings update, the

Ardent Health (ARDT) Q2 EPS Jumps 126%
Ardent Health (ARDT) Q2 EPS Jumps 126%

Ardent Health (NYSE:ARDT), a major hospital and healthcare system operating in fast-growing mid-sized urban markets, reported second quarter 2025 results on August 5, 2025. The earnings release

Is It Time to Buy Biotech Stocks?
Is It Time to Buy Biotech Stocks?

In this podcast, Motley Fool analysts Tim Beyers and Karl Thiel discuss:

To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. When you're ready to invest

Charles River (CRL) Q2 EPS Jumps 11%
Charles River (CRL) Q2 EPS Jumps 11%

Charles River Laboratories International (NYSE:CRL), a global provider of laboratory services and research models for drug development, announced its latest earnings results on August 6, 2025. The

Riot (RIOT) Q2 2025 Earnings Call Transcript
Riot (RIOT) Q2 2025 Earnings Call Transcript

Image source: The Motley Fool.

Thursday, July 31, 2025, at 4:30 p.m. ET

For analyst commentary or quotes, please email [email protected]

Continue reading

Source Fool.com

Xencor (XNCR) Q2 Revenue Jumps 82%
Xencor (XNCR) Q2 Revenue Jumps 82%

Xencor (NASDAQ:XNCR), a clinical-stage biopharmaceutical company focused on engineered antibodies for serious diseases, reported second quarter 2025 results on August 6, 2025. The company’s GAAP